Serum Cytokine Alterations Associated with Age of Patients with Nephropathia Epidemica
Table 2
Prevalence of clinical symptoms according to severity of disease and age.
Symptom
Symptom class
Symptom severity prevalence (CL95)
Sex
Sex prevalence (CL95)
Age class
Age prevalence (CL95)
Nose bleed
1
4.0 (0.21-19.56)
Male
16.2 (11.35-22.47)
1
17.2 (9.27-29.07)
2
9.9 (4.44-19.94)
Female
0.0 (0.0-15.17)
2
7.7 (3.59-15.03)
3
30.3 (18.62-44.92)
NS
Petechia
1
0.0 (0.0-13.36)
Male
18.8 (13.51-25.42)
1
23.0 (13.63-35.72)
2
4.9 (1.47-13.63)
Female
4.5 (0.24-22.21)
2
5.8 (2.46-12.31)
3
57.6 (42.87-71.27)
NS
Scleral bleed
1
0.0 (0.0-13.36)
Male
6.8 (3.89-11.63)
1
6.9 (2.45-16.61)
2
2.5 (0.38-10.00)
Female
0.0 (0.0-15.17)
2
3.8 (1.27-9.77)
3
18.2 (9.31-31.91)
NS
NS
Bleeding
1
4.0 (0.21-19.56)
Male
29.1 (22.67-36.33)
1
32.2 (21.14-45.12)
2
17.3 (9.56-28.64)
Female
4.5 (0.24-22.21)
2
13.5 (7.73-21.77)
3
60.0 (45.93-74.10)
NS
Cough
1
28.0 (13.37-47.97)
Male
5.1 (2.66-9.50)
1
3.4 (0.69-11.86)
2
7.4 (2.85-16.76)
Female
31.8 (15.18-54.65)
2
19.2 (12.41-28.34)
3
0.0 (0.0-8.04)
Diarrhea
1
12.0 (3.36-30.31)
Male
35.0 (28.14-42.53)
1
35.6 (24.26-48.58)
2
32.1 (21.46-44.55)
Female
31.8 (15.18-54.65)
2
23.1 (15.34-32.69)
3
42.2 (28.73-57.13)
NS
NS
Vomiting
1
8.0 (1.45-25.59)
Male
35.0 (28.14-42.53)
1
41.4 (29.15-54.36)
2
34.6 (23.60-47.03)
Female
31.8 (15.18-54.65)
2
23.1 (15.34-32.69)
3
54.5 (39.81-68.37)
NS
Nausea
1
36.0 (19.57-56.08)
Male
57.3 (49.76-64.51)
1
41.4 (29.15-54.36)
2
48.1 (35.63-60.69)
Female
31.8 (15.18-54.65)
2
23.1 (15.34-32.69)
3
78.8 (64.27-88.59)
NS
Abdominal pain
1
28.0 (13.37-47.97)
Male
67.5 (60.08-74.20)
1
70.1 (57.20-80.62)
2
59.3 (46.76-71.06)
Female
27.3 (12.61-50.00)
2
46.2 (36.45-56.34)
3
90.0 (78.91-96.71)
Back pain
1
44.0 (25.60-64-25)
Male
65.8 (58.32-72.55)
1
69.0 (56.05-79.75)
2
63.0 (50.48-74.10)
Female
59.1 (38.26-77.78)
2
57.7 (47.53-67.39)
3
84.8 (71.35-93.03)
NS
NS
Anuria
1
0.0 (0.0-13.36)
Male
14.5 (9.91-20.59)
1
17.2 [9.27-29.07)
2
0.0 (0.0-6.07)
Female
4.5 (0.24-22.21)
2
5.8 (2.46-12.31)
3
54.5 (39.81-68.37)
Oliguria
1
20.0 (8.23-39.84)
Male
72.6 (65.46-78.85)
1
75.9 [63.12-85.47)
2
70.4 (57.93-80.52)
Female
45.5 (26.05-66.17)
2
55.8 (45.60-65.46)
3
100.0(91.96-100.0)
NS
Fog eye
1
16.0 (5.66-35.74)
Male
54.7 (47.19-62.00)
1
59.8 (46.79-72.00)
2
44.4 (32.65-56.96)
Female
13.6 (3.83-33.82)
2
28.8 (20.64-38.90)
3
81.8 (68.09-90.69)
,, and . For severity classes: 1, mild; 2, moderate; and 3, severe. The sample sizes for each class were 25, 81, and 33, respectively. and . Number of patients for age classes 1 (≤40 years old) and 2 (>40 years old) were 87 and 52, respectively. Prevalence is the percentage (%) of subjects showing the symptom in the relevant data subset. Cl95 are the 95% confidence limits. For further details, see text.
